跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 151 条关于
“Vividion”
全部
151
临床试验
86
药物
9
机构
14
资讯
42
去年
Vividion's STX-478: A Novel Allosteric Inhibitor Targeting Mutant PI3Kα in Cancer
去年
Vividion Therapeutics Initiates Phase I Trial of Novel RAS-PI3Kα Inhibitor for Advanced Solid Tumors
去年
Vividion Secures Exclusive Rights to First-in-Class WRN Inhibitor VVD-214 for MSI-High Cancers
8个月前
Vividion's WRN Inhibitor VVD-214 Shows Promise for MSI-High Cancers in Journal of Medicinal Chemistry Publication
2年前
ACS Fall 2024: Novel Small Molecules in Clinical Development Unveiled
11个月前
Novel RAS-PI3K Inhibitor Enters Clinical Trials, Targeting Cancer Growth Without Metabolic Side Effects
10个月前
WRN Inhibitors Enter Clinical Development Phase as Precision Oncology Market Expands
10个月前
STAT Inhibitor Pipeline Expands with 22 Drugs Across 18 Companies Targeting Cancer and Inflammatory Diseases
9个月前
GSK Terminates Five-Year Cancer Partnership with Ideaya Biosciences, Returns Two Synthetic Lethality Programs
4个月前
Bayer Acquires Perfuse Therapeutics for $2.45 Billion to Advance Novel Glaucoma and Diabetic Retinopathy Treatment
第 1 页,共 5 页
上一页
下一页